DE-111 Ophthalmic Solution

DE-111 ophthalmic solution · Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-111 Ophthalmic Solution, covering 2015-05-14 to 2015-05-14. Get the full timeline:

Most recent: Clinical Trial Update: DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]